August 2, 2017 / 11:51 AM / in 2 months

BRIEF-Antibe Therapeutics receives approval to initiate phase 2 gastrointestinal endoscopy clinical trial

Aug 2 (Reuters) - Antibe Therapeutics Inc

* Antibe Therapeutics receives approval to initiate phase 2 gastrointestinal endoscopy clinical trial

* Antibe Therapeutics Inc - ‍it is anticipated that study will be completed in early 2018 for ​

* Antibe Therapeutics Inc - study is expected to begin immediately, and will be performed by Topstone Research, in Toronto Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below